Search for: "Acorda Therapeutics Inc."
Results 21 - 40
of 49
Sort by Relevance
|
Sort by Date
2 Nov 2016, 10:16 am
Acorda Therapeutics, Inc. [read post]
18 Oct 2016, 8:23 pm
Acorda Therapeutics Inc. 16-360 Issue: Whether the mere filing of an abbreviated new drug application by a generic pharmaceutical manufacturer is sufficient to subject the manufacturer to specific personal jurisdiction in any state where it might someday market the drug. [read post]
13 Oct 2016, 6:50 am
Acorda Therapeutics, et al., No. 16-360 (does an ANDA filing create nationwide specific jurisdiction?) [read post]
28 Sep 2016, 5:03 pm
Acorda Therapeutics, Inc. [read post]
28 Sep 2016, 5:03 pm
Acorda Therapeutics, Inc. [read post]
28 Sep 2016, 8:39 am
Acorda Therapeutics, et al., No. 16-360 Anticipation: Grunenthal GmbH v. [read post]
2 Sep 2016, 2:15 am
In Acorda Therapeutics, Inc. v. [read post]
25 Aug 2016, 6:34 am
Acorda Therapeutics, Inc., 823 F.3d 51, 63 (2d Cir. 2016). [read post]
18 May 2016, 6:27 am
Acorda Therapeutics, Inc., --- F.3d ----, 2016 WL 2848911, No. 14–4353–cv (2d Cir. [read post]
3 May 2016, 9:00 pm
March 18, 2016) [Patently-O Discussion]. [3] Acorda Therapeutics Inc. [read post]
2 May 2016, 6:17 am
The post Acorda Therapeutics v. [read post]
2 May 2016, 6:17 am
The Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
29 Apr 2016, 9:37 am
Beverly Hills Fan,21 F.3d at 1565; see also Acorda Therapeutics Inc. v.Mylan Pharm. [read post]
18 Mar 2016, 2:04 pm
The federal circuit’s decision came down today in Acorda Therapeutics Inc. v. [read post]
26 Jan 2016, 11:23 am
**As one small footnote, Ampyra is not a disease-modifying treatment for MS, in contrast to Copaxone or Tecfidera.link to BNA report: http://www.bna.com/acorda-par-settle-n57982066522/ [read post]
12 Oct 2015, 12:22 am
In August 2015, Bass failed in his challenge to two patents by Acorda Therapeutics Inc for Ampyra, a drug used to treat multiple sclerosis [noted by theAmeriKat here, while many readers were on holiday]. [read post]
5 Sep 2015, 11:58 am
”Bass has filed nine petitions challenging patents since Aug. 24, the day the Patent Trial and Appeal Board declined to review two Acorda Therapeutics Inc. cases. [read post]
3 Sep 2015, 3:06 pm
EndoPharmaceuticals Inc., 438 F.3d 1123, 1134 (Fed. [read post]
25 Aug 2015, 9:09 am
The USPTO declined to initiate an inter partes review of two patents owned by Acorda Therapeutics, Inc. [read post]
24 Aug 2015, 5:37 pm
Acorda Therapeutics, IPR2015-00720 and IPR2015-00817, U.S. [read post]
